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DOES BILE PROTECT OR DAMAGE INTERSTITIAL  
CAJAL-LIKE CELLS IN THE HUMAN GALLBLADDER?
Abstract: The etiology of gallstone disease is considered to be multifactorial, including biliary cho-
lesterol hypersecretion, supersaturation and crystallization, stone formation, bile stasis and mucus 
hypersecretion and gel formation. Gallbladder hypomotility seems to be a key process that triggers 
the precipitation of cholesterol microcrystals from supersaturated lithogenic bile. The purpose of the 
current study was to determine whether ICLCs in the gallbladder were influenced by lithogenic bile. 
Gallbladder specimens were collected from 30 patients (8 males and 22 females) who underwent 
elective laparoscopic cholecystectomy for symptomatic gallstone disease. The control group consisted 
of 25 consecutive patients (11 males and 14 females) who received elective treatment for pancreatic 
head tumors. ICLCs were visualized in paraffin sections of gallbladders using double immunofluore-
scence protocol with monoclonal c-kit antibodies and mast cell tryptase. Cholesterol, phospholipid 
and bile acid concentrations were measured in bile samples obtained by needle aspiration from the 
gallbladder at the time of surgery. The number of ICLCs in the gallbladder wall was significantly lower 
in the study group than in the control group (3.35 ± 1.23 vs. 7.06 ± 1.82 cell/FOV in the muscularis 
propria; P < 0.001) and correlated with a significant increase in the cholesterol saturation index. The 
glycocholic and taurocholic acid levels were significantly elevated in the control subjects compared 
with the study group. The results suggest that bile composition may play an important role in the 
reduction of ICLC density in the gallbladder.
Key words: interstitial Cajal-like cells, gallstones, cholesterol saturation index, bile acids, bile lith-
ogenicity.
INTRODUCTION
In Europe, 10–20% of the population carry gallbladder stones [1–3]. Many gal-
lstones are silent, but symptoms and severe complications ensue in more than 
40% of patients above the age of 40 years, necessitating laparoscopic cholecy-
stectomy [3]. In developed countries, cholesterol gallstones account for 80–90% 
of the gallstones found at cholecystectomy [4]. The etiology of gallstone disease 
is considered to be multifactorial, including biliary cholesterol hypersecretion, 
supersaturation and crystallization, stone formation and growth, bile stasis and 
mucus hypersecretion and gel formation within the gallbladder. Gallbladder hy-
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pomotility may be a key factor in the pathogenesis of cholelithiasis because it 
allows time for cholesterol microcrystals to precipitate from lithogenic bile that 
is supersaturated with cholesterol [5–8]. 
In the light of recent data our knowledge of the physiology of alimentary tract 
has expanded by the study of a population of specialized cells, the so-called 
interstitial cells of Cajal (ICCs), which were first described by the Spanish neu-
ropathologist, Ramon Santiago y Cajal in 1889 [9]. These cells have been suc-
cessfully identified using modern techniques, including immunohistochemistry 
and electron microscopy [10–12]. ICCs are found along the entire gastrointestinal 
tract, mostly in close proximity to smooth muscle. ICCs are considered to play 
an important role in smooth muscle motility. ICCs generate slow waves in phasic 
gastrointestinal muscles, actively propagate slow waves, and mediate or transduce 
neural inputs from enteric motor neurons to smooth muscles [13]. One important 
advance in ICC identification was the recognition that ICCs express the proto-on-
cogene c-kit, which encodes the transmembrane tyrosine kinase receptor protein 
c-Kit (CD117) [14–16]. Although the shapes of ICCs vary among species, tissues 
and tissue layers, all ICCs have the same immunophenotypic characteristics. 
Therefore, the c-Kit receptor is a reliable marker of ICCs. 
The interstitial cells of Cajal were also found in multiple non-enteric organs 
and referred as to interstitial Cajal-like cells (ICLC), however their morphology 
and function were best understood in the gastrointestinal system. In the gut, they 
are believed to act as pacemaker cells, and their loss or dysfunction has been 
linked to a variety of intestinal motility disorders [17–19]. Therefore, a decrease 
in the density of ICLCs in the muscle layer of the gallbladder could induce bile 
stasis and lead to gallstone formation. 
The aim of this study was to determine whether ICLC loss was related either 
to the degree of bile lithogenicity, which was expressed as a lithogenic index 
(cholesterol saturation index, CSI), or to the bile salt concentrations in patients 
who suffer from cholecystolithiasis and gallstone-free controls.
MATERIALS AND METHODS
SUBJECTS
Thirty consecutive patients with symptomatic gallstone disease were scheduled for 
elective surgery (laparoscopic cholecystectomy) and enrolled to the study group 
(8 males, mean age 51.9 ± 10.7 y; 22 females, mean age 52.9 ± 15.1 y) (Table 1). 
The presence of gallstones in the gallbladder was confirmed on ultrasound exa-
mination before the operation. They presented with mild, recurrent episodes of 
biliary colic. None of these patients had associated choledocholithiasis or acute 
cholecystitis. The control group consisted of 25 consecutive patients (11 males, 
mean age 62.0 ± 7.6 y; 14 females, mean age 61.0 ± 9.8 y), who were electively 
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treated for pancreatic head tumors and had no pre- or intraoperative signs of cho-
lelithiasis or jaundice (Table 1). Pancreaticoduodenectomy was performed accor-
ding to the standard Whipple procedure or the pylorus-sparing Traverso-Longmire 
technique in patients with resectable lesions. For patients with non-resectable 
lesions, retrocolic gastroenterostomy with Braun anastomosis was carried out for 
palliative treatment. Gallbladders that were not affected by primary tumors and 
did not contain any gallstones were routinely removed. Serum bilirubin levels 
were measured preoperatively and were normal in both groups. All patients were 
surgically treated in the First Chair of General, Oncological and Gastrointestinal 
Surgery at the Jagiellonian University Medical College in 2010.
T a b l e  1
Epidemiological data of patients enrolled in the study.
Male Female
Study group
n 8 22
mean age ± SD 51.9 ± 10.7 52.9 ± 15.1
Control group
n 11 14
mean age ± SD 62.0 ± 7.6 61.0 ± 9.8
Total
n 19 36
mean age ± SD 56.9 ± 10.94 54.8 ± 13.6
n — number of patients
ETHICAL APPROVAL AND CONSENT
All surgical samples were retrieved with ethical approval of the Jagiellonian Uni-
versity Bioethical Committee (KBET/30/B/2010), and after full written informed 
patient consent.
SPECIMENS
Small tissue samples from fresh gallbladder specimens were rinsed with PBS 
(phosphate-buffered saline, 0.01 M, pH = 7.4), fixed in 4% phosphate-buffered 
paraformaldehyde, processed and embedded in paraffin. Serial sections were cut 
and mounted on poly-L-lysine-coated glass slides and stained with hematoxylin 
and eosin (H&E) for routine histopathology. 
DOUBLE IMMUNOFLUORESCENCE PROTOCOL
Indirect double immunofluorescence after heat-induced epitope retrieval was used 
to allow the simultaneous visualization of two antigens. The sections were in-
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Fig. 1. Block diagram illustrating the steps of double immunostaining protocol applied in the study.
T a b l e  2 
Primary antibodies used for immunohistochemical reactions.
Antibody Species/clonality Dilution
Manufacturer,
Catalog number
Human C-kit/CD117 rabbit/policlonal 1:150 Dako, Glostrup, Dania, A4502
Human mast cell tryptase mouse/monoclonal 1:800 Dako, M7052
Antigen retrieval
micrwaving, 250 W, temp. 96oC, citric buffer pH = 6
Blocking
5% normal goat serum, 0,5% Triton X-100
rabbit anti-
c-kit/CD117
mouse anti-
tryptase
goat anti-rabbit
conjugated to Cy3
biotinylated
goat anti-mouse
DTAF-conjugated
streptavidin
Nuclei counterstaining (DAPI)
Closing (Vectashield)
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cubated overnight with a mixture of rabbit polyclonal anti-c-Kit antibody (anti
-CD117; A4502; Dako, Glostrup, Denmark; diluted 1:150) and mouse monoclonal 
anti- mast cell tryptase antibody (M7052; Dako; 1:800) (Table 2). The sections 
were rinsed in PBS and incubated for 1 h at room temperature with a mixture of 
a Cy3-conjugated goat anti-rabbit antibody (111-165-144; Jackson ImmunoRese-
arch, West Grove, PA, USA; 165-144; 1:600) and a biotinylated goat anti-mouse 
antibody (115-065-146; Jackson IR; 1:600). After washing in PBS, the slides were 
incubated with DTAF-conjugated streptavidin (016-010-084; Jackson IR; 1:500 
in PBS) for 1 h. After a final rinse in PBS, the nuclei were counterstained with 
DAPI (D9542; Sigma, St. Louis, MO, USA; 1:30,000) for 30 s. The sections were 
mounted in Vectashield medium (H-1000; Vector Laboratories, Burlingame, CA, 
USA) to minimize fluorophore photobleaching (Fig. 1).
MICROSCOPIC EXAMINATION  
AND QUANTIFICATION OF ICLCS
Microscopy images were captured using Olympus AnalySIS FIVE software on 
an Olympus BX50 epifluorescence microscope (Olympus, Tokyo, Japan) with an 
Olympus DP71 digital CCD camera and stored as .TIFF files. Concurrent mast 
cell tryptase staining enabled c-Kit-positive mast cells to be distinguished from 
ICLCs. The distribution of ICLCs in the gallbladder corpus was quantitatively 
assessed by applying the criteria for ICCs (c-Kit positive and tryptase negative). 
These cells were counted in 10 consecutive high-power fields (400×). The data 
were expressed as a mean number of cells per 1 field of view (FOV) of gallbladder 
muscularis propria. 
GALLBLADDER BILE COLLECTION, SAMPLE ANALYSIS  
AND LITHOGENECITY INDEX CALCULATION
Bile specimens were obtained from all subjects by needle aspiration of the gall-
bladder during surgery. Aliquots of bile samples were stored at –70oC prior to 
biliary lipid composition analysis. The cholesterol and phospholipid concentra-
tions and bile acid levels in the bile samples were determined. 
The bile samples were extracted on SEP-PACK-NH2 columns (500 mg, Waters, 
USA). Each column was first activated using 6 ml of n-hexane; then, 0.1 ml of 
centrifuged bile sample was applied to the column, and the flow-through was 
discarded. The samples were eluted in three 1-ml volumes of a chloroform-isopro-
panol mixture (3:1, v/v), followed by three 1-ml volumes of methanol. The eluted 
fractions from each column were collected and dried at 50oC under nitrogen.
The dry residues were reconstituted in 0.5 ml of isopropanol and mixed vi-
gorously. Cholesterol (Randox Laboratories Ltd., UK) and phospholipid (Wako 
Chemicals, Neuss, Germany) concentrations were measured by enzymatic 
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methods. The intra- and interassay coefficient of variations were 3% and 
4.8% for cholesterol and 5% and 6% for phospholipids, respectively. All de-
terminations were performed with a Cobas-Bio analyzer (Roche).
Individual bile acids were measured by reverse-phase high-performance 
liquid chromatography with an isocratic solvent system (Waters, USA). Prior 
to chromatographic separation, bile acids were extracted from bile samples 
using SEP-PACK C18 columns (Waters, USA). All columns were activated 
using 5 ml of methanol and 5 ml of water, after which 0.1 ml of bile mixed 
with phosphate buffer (0.07 mmol/l, pH 7.0) and 0.1 ml of internal standard 
were applied. Then, the columns were washed with 10 ml of water, 3 ml of 
10% acetonitrile and another 10 ml of water. The bile acids were eluted in 
3 ml of methanol. The eluates were dried at 37oC under nitrogen, and dry 
residues were re-dissolved in 1 ml of an acetonitrile-water mixture (1:1, v/v). 
Each sample was filtered using a Millex GN filter (13 mm) and separated 
chromatographically using an XTERRA RPC-18 column (18.5 μm × 3.9 mm × 
150 mm, Waters, USA) with detection at 200 nm.
The mobile phase (flow rate 2 ml/min) contained 10% acetonitrile in 
a mixture of methanol and 0.1 M monobasic potassium phosphate (60:40, 
v/v, pH 4.50). Before use, the solvent was filtered through a 0.45 μm filter 
(type HV, Millipore, Bedford, MA, USA). An elution profile of conjugated bile 
acid standards (Sigma, St. Louis, MO, USA) was obtained by injecting 20 μl 
of a standard bile acid mixture in methanol that contained glycocholic acid 
(1.640 mmol/l), taurocholic acid (1.488 mmol/l), glycochenodeoxycholic acid 
(1.696 mmol/l), glycodeoxycholic acid (1.696 mmol/l), taurochenodeoxycholic 
acid (1.532 mmol/l) and taurodeoxycholic acid (1.532 mmol/l). 
Based on cholesterol, phospholipid and total bile acid concentrations, the 
cholesterol saturation index (CSI) also known as lithogenecity index was obtained 
from Carey’s critical tables [20, 21]. Bile samples with a CSI equal to 1 or more 
were considered supersaturated.
DATA ANALYSIS AND STATISTICAL EVALUATION
The data were expressed as mean and standard deviation (SD). The results were 
analyzed using a one-way analysis of variance (ANOVA), followed by a post-hoc 
LSD test. Pearson’s correlation test was used to examine the relationship be-
tween continuous variables. P values less than 0.05 were considered to indicate 
statistical significance. All statistical analyses were performed using STATISTICA 
9.0 software (StatSoft, Tulsa).
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RESULTS
The interstitial Cajal-like cells were identified as c-Kit-positive nucleated cells 
with no co-expression of mast cell tryptase. ICLCs were located predominantly 
in the gallbladder corpus, but were also spotted occasionally in its fundus and 
neck. ICLCs had a centrally located nucleus and were showing characteristic 
spindle morphology; nevertheless, sparse, round tryptase-negative/c-Kit-positive 
cells were also present. Numerous ICLCs were detected, mostly in the muscula-
ris propria, and some ICLCs were observed in the connective tissue separating 
smooth muscle bundles (Fig. 2). 
Fig. 2. Cross-section of the gallbladder wall stained for CD117 (red) and tryptase (green).  
The nuclei are counterstained with DAPI (blue). CD117-positive/tryptase-negative ICLCs (arrows) 
and CD117-positive/tryptase-positive mast cells (arrowheads) are indicated.
The number of ICLCs in the gallbladder wall corpus was significantly lower in 
the study group than in the control group (3.35 ± 1.23 vs. 7.06 ± 1.82 cell/FOV 
in the muscularis propria; P < 0.001) (Table 3). 
Mast cells were present in all layers of the gallbladder wall and predominan-
tly localized to the lamina propria. In immunostained slides, c-Kit and tryptase 
double-positive mast cells were generally round or oval shaped, with a centrally 
located nucleus.
Using mast cell tryptase to identify and distinguish c-kit positive mast cells 
from ICLCs highlighted the morphological variability in mast cells in these spe-
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cimens and the potential for misidentification with conventional c-kit immunohi-
stochemistry.
The study revealed a significant decrease in the mean concentrations of gly-
cocholic and taurocholic acids in the bile from patients with cholelithiasis as com-
pared with the controls (P < 0.02 and P < 0.05, respectively). Furthermore, there 
was also a positive correlation between the ICLC count and the concentrations 
of glycocholic (r = 0.45, P = 0.039) and taurocholic (r = 0.32, P = 0.05) acids.
No significant differences in the concentrations of the other bile acids exa-
mined (glycochenodeoxycholic, glycodeoxycholic, taurochenodeoxycholic and 
taurodeoxycholic acid) were observed between the 2 groups of patients. There 
were also no significant differences in the concentrations of cholesterol, bile salts 
or phospholipids in the bile between the 2 groups (Table 4). 
T a b l e  4
Biliary lipid composition of gallbladder bile sampled at the time of surgery (mmol/l).  
Data are mean ± standard deviation (SD).
 Study group Control group
 Mean value SD Mean value SD
BS 92.96 54.78 114.1 65.74
PC 32.38 17.57 31.89 21.27
Ch 8.72 6.44 7.74 6.57
GCA 35.66 16.66 43.44 32.40
TCA 9.00 7.66 15.18 11.09
GCDCA 24.64 14.94 25.71 16.41
GDCA 22.00 13.24 17.23 16.57
TCDCA 8.64 6.55 9.69 7.00
TDCA 3.01 1.46 2.34 1.30
BS — bile salts, PC — phospholipids, Ch — cholesterol, GCA — glycocholic acid, TCA — taurocholic acid, GCDCA 
— glycochenodeoxycholic acid, GDCA — glycodeoxycholic acid, TCDCA — taurochenodeoxycholic acid, TDCA — 
taurodeoxycholic acid
T a b l e  3
Number of ICLCs per field of view and mm2 of tissue. Study group vs control group.
 Study group Control group
 Mean value SD 95% CI Mean value SD 95% CI
ICLC/FOV  3.35  1.24 2.85–3.85  7.06  1.82 6.20–7.40
ICLC/mm2 of tissue 26.27 11.27 22.06–30.48 56.42 14.62 49.58–63.26
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The calculated cholesterol saturation index was significantly higher in patients 
with cholecystolithiasis (1.23 ± 0.84) than in the controls (0.78 ± 0.33) (P < 0.05). 
The results revealed an important negative correlation (r = –0.62, P = 0.001) 
between the CSI and the ICLC count in the gallbladder wall. 
DISCUSSION
The discovery that ICC could be labeled with antibodies to the c-kit, a tyrosine 
kinase receptor coded by the proto-oncogene c-kit, led to the successful charac-
terization of ICC throughout the gut [22], which had only been thought possible 
previously using TEM.
Most importantly, the kit receptor is a specific marker for ICC and kit anti-
bodies have been used extensively to identify ICC in gastrointestinal tissues as 
well as in many extraintestinal organs where these cells are known as interstitial 
Cajal-like cells (ICLCs). We used paraffin sections labeled with c-kit to provide 
information about these cells in the human gallbladder. As a result, the ICLCs 
were found throughout the thickness of the gallbladder wall, from the gallblad-
der dome to the bladder neck. We reported a significant decrease in the density 
of ICLCs in the gallbladder wall in patients with gallstones. Twofold reduction of 
the number of interstitial Cajal-like cells may significantly affect motility of the 
gallbladder and result in cholelithiasis. Literature reports existence of correlation 
between reduced number of ICC in gastrointestinal diseases and abnormal gastro-
intestinal motility [23–25]. Numerous papers indicate presence of abnormalities 
of the gallbladder emptying in patients with cholecystolithiasis [26–28]. Two re-
cent studies in guinea pigs would support this. Lavoie et al. showed that the kit 
receptor regulates the excitability of gallbladder smooth muscle by modulating 
the generation and rhythmicity of electrical activity [29]. Xu et al. found that 
gallbladder contraction is mediated by CCK-A receptors and these are expressed 
by ICC [30]. On this basis one can hypothesize that abnormal gallbladder motility 
may result from low number of Cajal-like cells in the gallbladder wall and lead 
to abnormalities in bile outflow, ultimately with formation of concrements in its 
lumen. From a physiological point of view, Cajal-type of interstitial cells might 
represent, through analogy to the gastrointestinal tract an essential player in the 
physiology of a digestive cavitary organ such as gallbladder, imposing the rhythm 
of bile release (pace-maker cells). The presented results confirm our previous 
findings that the number of c-Kit immunopositive (concomitantly tryptase-im-
munonegative) cells that from the phenotypic point of view could correspond to 
Cajal-like cells, is reduced in patients with cholelithiasis [14]. Some authors cla-
im that impaired gallbladder motility is evoked by absorption of cholesterol from 
lithogenic bile through the gallbladder wall [31]. Excessive amounts of cholesterol 
in the smooth muscles of the gallbladder wall may stiffen the sarcolemmal mem-
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brane and impair the signal transduction mediated by protein G, resulting from 
CCK-A binding to its receptor, ultimately paralyzing the gallbladder contractility 
[32]. Therefore, we evaluated the cholesterol saturation index (CSI), which is an 
accepted parameter relevant to bile lithogenicity in both groups of patients [33]. 
We found an increased CSI in the patients with gallstones, which could be related 
to the loss of ICLCs. However, the exact mechanism underlying the destructive 
influence of bile on ICLCs remains still unclear. Our findings are supported by 
Hu et al., who demonstrated that the expression of c-Kit mRNA and c-Kit protein 
in the gallbladder wall were significantly decreased in the gallbladders of guinea 
pigs fed a high cholesterol diet [34]. However, the Hu et al. study provided in-
sight into the pathogenesis of gallstone formation, similar to the studies by Xu 
and Shaffer, by showing that gallbladder hypomotility resulted from increased 
cholesterol levels [35]. The excess cholesterol in the smooth muscle of the gall-
bladder attenuates the ability of the muscle to contract as a result of alterations 
in signal transduction, changes in ion channel activity, decoupled membrane 
receptor–ligand interactions and disturbances in contractile protein activity [36].
It has also been reported that chronic administration of imatinib may be 
related to increased gallstone formation in patients treated for chronic myelo-
genous leukemia. Imatinib is a specific tyrosine kinase inhibitor and is widely 
used in the treatment of GIST and other malignancies. Imatinib can increase the 
plasma estrogen levels via cytochrome P450-dependent metabolic pathways and 
possibly lead to increased cholesterol excretion with reduced excretion of biliary 
salts and the development of gallbladder stones [37]. Because imatinib damages 
ICLCs, gallstone formation could be directly related to the loss of ICLCs in the 
gallbladder wall. 
The observed decrease in the number of ICCs in the gallbladder wall of patients 
with cholelithiasis in our study must be taken into consideration as a possible 
mechanism underlying gallbladder dysmotility resulting from the increased lith-
ogenic properties of bile. The role of ICLCs in the regulation of bile duct motility 
appears to be an important pathological factor in gallstone disease. 
Altered composition of bile in patients with cholelithiasis influences ICLCs 
within the gallbladder musculature. Considering the pivotal role of interstitial 
Cajal-like cells in the regulation of gallbladder and extrahepatic bile duct motili-
ty, we conclude that a reduction in ICLC number may be a consequence of the 
toxicity of the supersaturated bile, while some other bile components (glycocholic 
and taurocholic acids) may exert protective effects on ICLCs. 
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LIST OF ABBREVIATIONS
ICC — interstitial cells of Cajal
ICLC — interstitial Cajal-like cells
CSI  — cholesterol saturation index
H&E  — hematoxylin and eosin
FOV  — field of view
ANOVA — one-way analysis of variance
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